Article
PGD to reduce reproductive risk: the case of mitochondrial DNA disorders.
Human reproduction (Oxford, England) - 1 Nov 2008
Bredenoord A L, Dondorp W, Pennings G, De Die-Smulders C E M, De Wert G
Abstract excerpt
This paper discusses the pros and cons of introducing PGD for mitochondrial DNA (mtDNA) disorders such as NARP (Neurogenic muscle weakness, Ataxia, Retinis Pigmentosa)/Leigh, MELAS (Mitochondrial myopathy, Encephalopathy, Lactic acidosis, and Stroke-like episodes), private mtDNA mutations and LHON (Leber Hereditary Optic Neuropathy). Although there is little experience with PGD for mtDNA disorders, it is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.